Navigation Links
Cryopreservation of Ovaries for Cancer patients undergoing treatment

Researchers from Israel has found a new method of Cryopreservation of ovaries for few years and then reimplanting them into the same women. The procedure would be very useful for women with cancer, because during cancer // hormonal treatment, the chances of women getting infertile is very high. This method involves removing the ovaries then freezing them till required, when the treatment for cancer is finished the ovaries can be implanted back into them and the women can give birth a child. This Cryopreservation technique not only useful for women undergoing cancer treatment it will be also useful in organ transplants storage, which is now required to be done with in hours of donation. "There is a lot of research still to be done, but we hope that it will not take more than a few years for this to become a practicable option for women, such as young cancer patients, who would otherwise be left infertile after their treatment," said Yehudit Nathan, program manager at Core Dynamics, the biotech company that funded and provided technical expertise for the exercise. Dr. Amir Arav, Senior Scientist at the Institute of Animal Sciences at Agricultural organization, Bet Dagan said that their Cryopreservation technique involves removing the entire ovaries and cyropreserving them till required for several years and this procedure is different from earlier procedures, where only a part of the ovaries is cryopreserved and replanted into the women which may activate the already present ovaries.

"This approach could revolutionize the field of Cryopreservation [frozen storage] for diverse human applications, such as organ transplants, as well as helping women who face the loss of their fertility," he said. However, it might be necessary for women to go through IVF because of damage to the ovary, he said.

The procedure was successfully tested in sheep’s in which the right ovary of the sheep was removed from eight sheep’s and were cryopreserved, after a fort
'"/>




Page: 1 2

Related medicine news :

1. Cryopreservation of embryo eggs
2. Fibroids unlikely to Turn Cancerous
3. Virus Level could Predict Cervical Cancer Risk
4. Cancer Doctors Okays Controversial Prostate Therapy
5. Potential New Cancer Gene Identified
6. Consensus on "Combination Therapy" for Breast Cancer
7. Cancers of Colon & Rectum linked to Cigarette Smoking
8. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
9. The Cancer Rumour mill working over time
10. Cancer drugs in development nearly doubled since 1995
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:U.S. Cancer Cases, Deaths Continue to Drop 2Health News:U.S. Cancer Cases, Deaths Continue to Drop 3Health News:U.S. Cancer Cases, Deaths Continue to Drop 4Health News:New approach to sickle-cell disease shows promise in mice 2Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 2Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 3Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 4Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 5
Breaking Medicine Technology:CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 3Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults 2Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 1Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 2Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 3Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 4Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 5Pelosi and Hoyer Remarks at Press Availability Following Leadership Meeting 58494 1Pelosi and Hoyer Remarks at Press Availability Following Leadership Meeting 58494 2Pelosi and Hoyer Remarks at Press Availability Following Leadership Meeting 58494 3Pelosi and Hoyer Remarks at Press Availability Following Leadership Meeting 58494 4Showers Expected on Michigan Avenue Friday 21 58490 1